Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level

被引：0
|
作者：
Sai-Lan Liu
Xue-Song Sun
Hao-Jun Xie
Qiu-Yan Chen
Huan-Xin Lin
Hu Liang
Yu-Jing Liang
Xiao-Yun Li
Jin-Jie Yan
Chao Lin
Zhen-Chong Yang
Shan-Shan Guo
Li-Ting Liu
Qing-Nan Tang
Yu-Yun Du
Lin-Quan Tang
Ling Guo
Hai-Qiang Mai
机构：
[1] Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
[2] Sun Yat-sen University Cancer Center,Department of Nasopharyngeal Carcinoma
[3] Sun Yat-sen University Cancer Center,Department of Radiation Oncology
来源：
BMC Cancer | / 20卷
关键词：
Nasopharyngeal carcinoma; Induction chemotherapy; Prognosis; Plasma Epstein–Barr virus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma
    Liu, Li-Ting
    Tang, Lin-Quan
    Chen, Qiu-Yan
    Zhang, Lu
    Guo, Shan-Shan
    Guo, Ling
    Mo, Hao-Yuan
    Zhao, Chong
    Guo, Xiang
    Cao, Ka-Jia
    Qian, Chao-Nan
    Zeng, Mu-Sheng
    Bei, Jin-Xin
    Hong, Ming-Huang
    Shao, Jian-Yong
    Sun, Ying
    Ma, Jun
    Mai, Hai-Qiang
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (04): : 862 - 869
  • [32] Plasma Epstein-Barr Virus DNA Level Strongly Predicts Survival in Metastatic/Recurrent Nasopharyngeal Carcinoma Treated With Palliative Chemotherapy
    An, Xin
    Wang, Feng-Hua
    Ding, Pei-Rong
    Deng, Ling
    Jiang, Wen-Qi
    Zhang, Li
    Shao, Jian-Yong
    Li, Yu-Hong
    CANCER, 2011, 117 (16) : 3750 - 3757
  • [33] Is pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma?
    Jin, Ya-Nan
    Yao, Ji-Jin
    Zhang, Fan
    Wang, Si-Yang
    Zhang, Wang-Jian
    Zhou, Guan-Qun
    Qi, Zhen-Yu
    Sun, Ying
    JOURNAL OF CANCER, 2017, 8 (06): : 976 - 982
  • [34] Correlation between plasma Epstein-Barr virus DNA and clinical response to pembrolizumab in patients with advanced or metastatic nasopharyngeal carcinoma
    Kao, H. F.
    Hsu, C.
    Huang, H. C.
    Wang, C. W.
    Cheng, J. D.
    Hong, R. L.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S576 - S576
  • [35] Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma
    Ma, Brigette B. Y.
    King, Ann
    Lo, Y. M. Dennis
    Yau, Y. Y.
    Zee, Benny
    Hui, Edwin P.
    Leung, Sing F.
    Mo, Frankie
    Kam, Michael K.
    Ahuja, Anil
    Kwan, Wing H.
    Chan, Anthony T. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : 714 - 720
  • [36] Prognostic Value of Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma with Low Pre-treatment Epstein-Barr Virus DNA: a Propensity-matched Analysis
    Peng, Hao
    Chen, Lei
    Li, Wen-Fei
    Guo, Rui
    Zhang, Yuan
    Zhang, Fan
    Liu, Li-Zhi
    Tian, Li
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    JOURNAL OF CANCER, 2016, 7 (11): : 1465 - 1471
  • [37] Efficacy and Toxicity of Three Induction Chemotherapy Regimens in Locoregionally Advanced Nasopharyngeal Carcinoma: Outcomes of 10-Year Follow-Up
    Peng, Hao
    Chen, Binbin
    He, Shuiqing
    Tian, Li
    Huang, Ying
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Quantification of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma: results of a prospective study
    Ozyar, E.
    Gultekin, M.
    Alp, A.
    Hascelik, G.
    Demir, C.
    Atahan, I. L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 325 - 325
  • [39] Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma Epstein-Barr virus DNA
    Chan, ATC
    Ma, BBY
    Lo, D
    Leung, SF
    Kwan, WH
    Hui, EP
    Mok, TSK
    Kam, M
    Chan, LS
    Chiu, SKW
    Yu, KH
    Cheung, KY
    Lai, K
    Lai, M
    Mo, F
    Yeo, W
    King, A
    Johnson, PJ
    Teo, PML
    Zee, B
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3053 - 3060
  • [40] The Role of Plasma Epstein-Barr Virus DNA in the Management of Recurrent Nasopharyngeal Carcinoma
    Chan, Jimmy Yu Wai
    Wong, Stanley Thian-Sze
    LARYNGOSCOPE, 2014, 124 (01): : 126 - 130
12345